| Followers | 3805 |
| Posts | 244703 |
| Boards Moderated | 0 |
| Alias Born | 07/30/2007 |
Friday, July 31, 2020 1:00:23 AM
Afterhours was .66 that would be almost $13.00 tomorrow morning. The ACHV float will be much lower if they are doing the split tonight. If not we are off to the races anyway because that means they will wait the next 6 months hopefully to just get back over $1.00. That could have happened this week if it had not been for all the RS panic sellers and shorts today. We ran to .82 plus this AM with ease until the fools hit. Based on yesterdays close we should open at $12.00 or much more if the RS is 20 to 1. Now if they run it like they ran TAOP today then we could run to $30.00 plus etc. That one went insane on huge volume. We would not even need that kind of volume. Plus those Chinese stocks are scams. ACHV is legit with a multi billion dollar drug.
Recent ACHV News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 10:20:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 10:16:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 08:47:39 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/16/2026 08:11:38 PM
- Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors • GlobeNewswire Inc. • 04/16/2026 12:57:06 PM
- Achieve Life Sciences Announces Up to $354 Million Private Placement • GlobeNewswire Inc. • 04/16/2026 12:53:49 PM
- Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/24/2026 08:12:47 PM
- Achieve Life Sciences reports fourth-quarter results in line with expectations • IH Market News • 03/24/2026 12:37:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 11:05:07 AM
- Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/24/2026 11:00:00 AM
- Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 • GlobeNewswire Inc. • 03/17/2026 12:30:00 PM
- Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:07:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:06:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:05:03 PM
- Achieve Life Sciences Announced Granting of New Hire Inducement Awards • GlobeNewswire Inc. • 01/30/2026 09:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/30/2026 05:15:28 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/23/2026 09:04:43 PM
- Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer • GlobeNewswire Inc. • 01/12/2026 01:47:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 01:10:03 PM
- Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week • PR Newswire (US) • 12/17/2025 09:11:00 PM
